Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Autor
Xia, Shuai
Liu, Meiqin
Wang, Chao
Xu, Wei
Lan, Qiaoshuai
Feng, Siliang
Qi, Feifei
Bao, Linlin
Du, Lanying
Liu, Shuwen
Qin, Chuan
Sun, Fei
Shi, Zhengli
Zhu, Yun
Jiang, Shibo
Lu Lu